The effect of oral nutrition supplement (ONS) on autologous hematopoietic stem cell transplantatio

Phase 2

Recruiting

• Conditions: Condition 1: Lymphoma. Condition 2: multiple myeloma.; Non-Hodgkin lymphoma, unspecified; Multiple myeloma; C85.9; C90.0

• Registration Number: IRCT20220208053971N2
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

Patients with lymphoma or multiple myeloma are candidates for autologous hematopoietic stem cell transplantation
Age range 18-50 years

Exclusion Criteria

Reluctance to cooperate

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Weight. Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: Seca Scales.;Body mass index(BMI). Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: Questionnaire and calculation.